. Author manuscript; available in PMC: 2025 Mar 10.

Published in final edited form as: Int J Drug Policy. 2025 Jan 23;137:104710. doi: 10.1016/j.drugpo.2025.104710

Table 1.

Participant age, reported history of injecting and point-of-care testing results (n=765).

Variable		n	%

Age (in years)	Median	32.5	-
	25^th percentile	27.5	-
	75^th percentile	38.2	-
Reports previous drug injecting	Never	748	97.8%
	Ever injected	17	2.2%
	> 12 months ago	11	1.4%
	3 – 12 months ago	3	0.4%
	< 3 months ago	3	0.4%
HIV positive	(n=765)	58	7.6%
HBsAg reactive	(n=765)	30	3.9%
HCV RNA detected	(n=665)	3	0.5%
HIV-HBV coinfection	(n=765)	9	1.2%

HBV: hepatitis B virus; HBsAg: hepatitis B surface antigen; HCV: hepatitis C virus; HIV: human immunodeficiency virus